Adults 3 to 19, any sex, with Problem Behavior or Self-injury. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Participants Showing Resurgence as Predicted by the Quantitative Model -- Highest Response RatePrimary· Through study completion, an average of 4 months.
Mean responses per minute of destructive during the resurgence test conditions are compared within-participant to determine whether response rates are highest in the test condition predicted by the model to produce the highest rate of responding.
Group
Value
95% CI
Evaluation of Treatment Dosage
1
Evaluation of Size of Decrease in Alternative Reinforcement
5
Number of Participants Showing Resurgence as Predicted by the Quantitative Model -- Lowest Response RateSecondary· Through study completion, an average of 4 months.
Mean responses per minute of destructive during the resurgence test conditions are compared within-participant to determine whether response rates are lowest in the test condition predicted by the model to produce the lowest rate of responding.
Group
Value
95% CI
Evaluation of Treatment Dosage
2
Evaluation of Size of Decrease in Alternative Reinforcement
6
Sponsor's own description
Background: Functional communication training (FCT) is a commonly used intervention for teaching appropriate communication skills to children with intellectual disabilities who exhibit severe destructive behavior. Resurgence as Choice (RaC) Theory, a quantitative model of behavior, may help to explain why treatment relapse often occurs after FCT. This project will use the predictions of RaC to improve FCT treatments.
Objective: To test the predictions made by RaC with human participants who exhibit severe destructive behavior.
Eligibility: Children between the ages of 3 and 19 who display destructive behavior that is maintained by social consequences, who have IQ and adaptive behavior scores between 35 and 70, who are on a stable psychoactive drug regimen (or drug free) for at least 10 half-lives of each medication with no anticipated changes, and who have a stable educational plan and placement will be be eligible to enroll.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT05445596 — Improving Treatment for Children With Intellectual and Developmental Disabilities and Problem Behavior in Schools
· NA
· terminated
Other recruiting trials for Problem Behavior
Currently open trials in the same condition.
NCT05928247 — Manualized Assessment and Treatment Model of Challenging Behavior
· NA
· recruiting
NCT06651606 — Preventing Relapse of Problem Behavior Through Behavioral Economics: A Translational Analysis
· NA
· recruiting
NCT05925101 — Basic and Applied Research on Extinction Bursts
· NA
· recruiting
NCT05537610 — Extensions of Resurgence as Choice
· NA
· recruiting
NCT05649839 — Design of a Prototype Garment Adapted to Demented Elderly Subjects With Disturbing Behavioral Problems in the Management
· NA
· active not recruiting
Other Rutgers, The State University of New Jersey trials
Trials by the same sponsor.
NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD)
· NA
· not yet recruiting
NCT06955130 — Lactate and Glycerol Contribution to Gluconeogenesis
· NA
· not yet recruiting
NCT06822010 — SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
· Phase 2
· not yet recruiting
NCT07525011 — Comparative Study of Denture Fabrication Techniques
· NA
· not yet recruiting
NCT06834204 — Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rutgers, The State University of New Jersey
Last refreshed: 3 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03423940.